StockDuty ← Dashboard Oct 02, 2026 08:49 PM ET
SignalFDA/Bio

Biogen phase 2 litifilimab data boosts lupus candidate

Biogen phase 2 litifilimab data boosts lupus candidate.

Biogen phase 2 litifilimab data boosts lupus candidate.
Biogen phase 2 litifilimab data boosts lupus candidate. — impact context not separately stored; see What changed.
Sources